Mycobacterium aurum (DSM 43999, ATCC 23366, JCM 6366)

Name: Mycobacterium aurum (DSM 43999, ATCC 23366, JCM 6366)
Creator: BacDive
License: http://creativecommons.org/licenses/by/4.0/

BacDive ID 8379

Type strain

Strain Designation 358, 14 121 0001

Culture col. no. DSM 43999 ATCC 23366 JCM 6366 NCTC 10437 CCUG 70546 11 more

NCBI tax ID(s) 1791

Special Collections DSMZ CCUG JCM KCTC CIP JMRC

History DSMZ <- J.R. Andreesen, Univ. Göttingen <- ATCC <- M. Tsukamura, 358 JCM <-- M. Tsukamura 15006. CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 121 0001 <- ATCC <- M. Tsukamura: strain 358

Links

Mycobacterium aurum 358 is an aerobe, rod-shaped bacterium that was isolated from soil.

rod-shaped aerobe genome sequence 16S sequence Bacteria

Name and taxonomic classification

SI-ID 13221

LMG 19255,ATCC 23366,DSM 43999,JCM 6366,NCTC 10437,CT1971-02373,CCUG 37666,CIP 104465,KCTC 9955,NRRL B-4037,HAMBI 2275,CNCTC 7257,CCUG 70546

@ref 20215

Last LPSN update 2026-05-29 08:26:51

Domain Bacteria

Phylum Actinomycetota

Class Actinomycetes

Order Mycobacteriales

Family Mycobacteriaceae

Genus Mycobacterium

Species Mycobacterium aurum

Full scientific name Mycobacterium aurum Tsukamura 1966 (Approved Lists 1980)

Synonyms (1)

Mycolicibacterium aurum

BacDive ID	Other strains from **Mycobacterium aurum** (13)	Type strain
8374	M. aurum L1, DSM 6695
8376	M. aurum 312, DSM 43537, ATCC 23070, NCTC 10438, SN ...
8377	M. aurum 326, DSM 43538, SN 2602
8378	M. aurum DSM 43539, SN 2605
8380	M. aurum DSM 44238
136728	M. aurum CIP 105694
136772	M. aurum CIP 105692
136773	M. aurum CIP 105691
136774	M. aurum CIP 105690
136778	M. aurum CIP 105688
136779	M. aurum CIP 105689
137077	M. aurum 14 121 0005 (A+ Rebuffet), CIP 104482
178768	M. aurum SB66, ST033708

Morphology

Cell morphology

@ref	Cell shape	Gram stain	Confidence
116641	rod-shaped
125439		positive	95.056
125438		positive	91.368

Multimedia

@ref:	11447
multimedia content:	DSM_43999-1.jpg
multimedia.multimedia content:	https://www.dsmz.de/microorganisms/photos/DSM_43999-1.jpg
intellectual property rights:	© Leibniz-Institut DSMZ
manual_annotation:	1

@ref:	11447
multimedia content:	DSM_43999.jpg
multimedia.multimedia content:	https://www.dsmz.de/microorganisms/photos/DSM_43999.jpg
caption:	Medium 645 37°C
intellectual property rights:	© Leibniz-Institut DSMZ
manual_annotation:	1

Culture and growth conditions

Culture medium

@ref	Name	Medium link	Composition
11447	MIDDLEBROOK MEDIUM (DSMZ Medium 645)	Medium recipe at MediaDive	Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water
11447	LÖWENSTEIN-JENSEN MEDIUM (DSMZ Medium 354)	Medium recipe at MediaDive	Name: LÖWENSTEIN-JENSEN MEDIUM (DSMZ Medium 354) Composition: Potato flour 18.6104 g/l L-Asparagin 2.23325 g/l KH2PO4 1.55087 g/l Mg-citrate 0.372208 g/l Malachite green 0.248139 g/l MgSO4 0.148883 g/l Glycerol Fresh egg mixture Distilled water
41184	MEDIUM 55 - for Mycobacterium
116641	CIP Medium 55	Medium recipe at CIP

Culture temp

@ref	Growth	Type	Temperature (°C)
11447	positive	growth	37
41184	positive	growth	37
63730	positive	growth	30
67770	positive	growth	37
116641	positive	growth	25-37
116641	negative	growth	10
116641	negative	growth	41
116641	negative	growth	45

Physiology and metabolism

Oxygen tolerance

@ref	Oxygen tolerance	Confidence
63730	aerobe
116641	obligate aerobe
125438	aerobe	90.391
125439	obligate aerobe	99.105

Halophily

@ref	Salt	Growth	Tested relation	Concentration
116641	NaCl	positive	growth	0-4 %
116641	NaCl		growth	6 %
116641	NaCl		growth	8 %
116641	NaCl		growth	10 %

Observation

67770

Observationquinones: MK-9(H₂)

Metabolite utilization

@ref	Chebi-ID	Metabolite	Utilization activity	Kind of utilization tested
68369	17128 ChEBI	adipate	-	assimilation	from API 20NE
68369	29016 ChEBI	arginine	-	hydrolysis	from API 20NE
68369	17634 ChEBI	D-glucose	-	assimilation	from API 20NE
68369	17634 ChEBI	D-glucose	-	fermentation	from API 20NE
68369	16899 ChEBI	D-mannitol	+	assimilation	from API 20NE
68369	16024 ChEBI	D-mannose	-	assimilation	from API 20NE
68369	27689 ChEBI	decanoate	-	assimilation	from API 20NE
116641	4853 ChEBI	esculin	+	hydrolysis
68369	4853 ChEBI	esculin	-	hydrolysis	from API 20NE
68369	5291 ChEBI	gelatin	-	hydrolysis	from API 20NE
68369	24265 ChEBI	gluconate	+	assimilation	from API 20NE
68369	30849 ChEBI	L-arabinose	+	assimilation	from API 20NE
68369	25115 ChEBI	malate	+	assimilation	from API 20NE
68369	17306 ChEBI	maltose	-	assimilation	from API 20NE
68369	59640 ChEBI	N-acetylglucosamine	-	assimilation	from API 20NE
116641	17632 ChEBI	nitrate	+	reduction
116641	17632 ChEBI	nitrate	-	respiration
68369	17632 ChEBI	nitrate	-	reduction	from API 20NE
116641	16301 ChEBI	nitrite	-	reduction
68369	27897 ChEBI	tryptophan	-	energy source	from API 20NE
68369	16199 ChEBI	urea	-	hydrolysis	from API 20NE

Metabolite production

@ref	Chebi-ID	Metabolite	Production
68369	35581 ChEBI	indole		from API 20NE
116641	35581 ChEBI	indole

Metabolite tests

@ref	Chebi-ID	Metabolite	Indole test	Voges-proskauer-test	Methylred-test
116641	15688 ChEBI	acetoin		-
116641	17234 ChEBI	glucose			-
68369	35581 ChEBI	indole	-			from API 20NE

Enzymes

@ref	Value	Activity	Ec
116641	alcohol dehydrogenase	-	1.1.1.1
68382	alpha-chymotrypsin	-	3.4.21.1	from API zym
68382	alpha-fucosidase	-	3.2.1.51	from API zym
68382	alpha-galactosidase	-	3.2.1.22	from API zym
68382	alpha-mannosidase	-	3.2.1.24	from API zym
116641	amylase	-
68369	arginine dihydrolase	-	3.5.3.6	from API 20NE
116641	beta-galactosidase	-	3.2.1.23
68382	beta-galactosidase	-	3.2.1.23	from API zym
68382	beta-glucosidase	-	3.2.1.21	from API zym
68369	beta-glucosidase	-	3.2.1.21	from API 20NE
68382	beta-glucuronidase	-	3.2.1.31	from API zym
116641	caseinase	-	3.4.21.50
116641	catalase	+	1.11.1.6
116641	DNase	-
68382	esterase lipase (C 8)	+		from API zym
116641	gamma-glutamyltransferase	+	2.3.2.2
116641	gelatinase	-
68369	gelatinase	-		from API 20NE
116641	lecithinase	-
68382	leucine arylamidase	+	3.4.11.1	from API zym
116641	lysine decarboxylase	-	4.1.1.18
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52	from API zym
68382	naphthol-AS-BI-phosphohydrolase	-		from API zym
116641	ornithine decarboxylase	-	4.1.1.17
116641	oxidase	-
116641	phenylalanine ammonia-lyase	-	4.3.1.24
116641	tryptophan deaminase	-
116641	urease	+	3.5.1.5
68369	urease	-	3.5.1.5	from API 20NE
68382	valine arylamidase	-		from API zym

API zym

@ref	Control	Alkaline phosphatase	Esterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	Lipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
11447	-	-	+/-	+	-	+	-	+/-	-	-	-	-	-	-	-	+/-	-	-	-	-
116641	-	+	+	+	+	+	-	+	+	-	+	-	-	-	-	-	-	-	-	-

API 20NE

@ref	Reduction of nitratesNO3	TRP	GLU_ Ferm	ADH (Arg)	URE	ESC	GEL	PNPG	GLU_ Assim	ARA	MNE	MAN	NAG	MAL	GNT	CAP	ADI	MLT	CIT	PAC	OX
11447	-	-	-	-	-	-	-	-	-	+	-	+	-	-	+	-	-	+	-	-	not determinedn.d.

API biotype100

@ref	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
116641	not determinedn.d.	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	-	-	-	-	-	-	-	-	-	-	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	+	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	+	-	-	-	-	-	-	-	+	-	+

Isolation, sampling and environmental information

Isolation source categories

Cat1	Cat2	Cat3
#Environmental	#Terrestrial	#Soil

Isolation

@ref	Sample type
11447	soil
63730	Soil
67770	Soil
116641	Environment, Soil

Interaction and safety

Risk assessment

@ref	Biosafety level	Biosafety level comment
11447	1	Risk group (German classification) According to TRBA 466
116641	1	Risk group (French classification) According to TRBA 466

Sequence information

Genome sequences

@ref	Description	Assembly level	INSDC accession	BV-BRC accession	IMG accession	NCBI tax ID	Score
66792	50279_F01 assembly for Mycolicibacterium aurum NCTC10437	complete	GCA_900637195	1791.6	8049331151	1791	99.2
67770	M_aurum assembly for Mycolicibacterium aurum NCTC 10437	scaffold	GCA_001049355		2740892265	1791	69.87
66792	ASM2582134v1 assembly for Mycolicibacterium aurum DSM 43999	scaffold	GCA_025821345	1791.10	8113820284	1791	67.62

16S sequences

@ref	Description	Accession	Length	NCBI tax ID
20218	Mycobacterium aurum strain ATCC 23366 16S ribosomal RNA gene, partial sequence	FJ172298	1453	1791
20218	Mycolicibacterium aurum 16S ribosomal RNA, complete sequence	M29558	1349	1791
20218	M.aurum 16S ribosomal RNA, part	X55595	1458	1791
20218	Mycobacterium aurum 16S ribosomal RNA gene, partial sequence	AY438068	540	1791

GC content

@ref	GC-content (mol%)	Method
67770	67.5	genome sequence analysis

Genome-based predictions

Predictions

Predictions from Deep Learning for Genome Sequence Data. R package version 0.3.1 based on: 50279_F01 assembly for Mycolicibacterium aurum NCTC10437
BV-BRC: 1791.6

@ref	Trait	Model	Prediction	Confidence in %	In training data
125439	oxygen_tolerance	BacteriaNetⓘ	obligate aerobe	99.11	no
125439	gram_stain	BacteriaNetⓘ	positive	95.06	no
125439	motility	BacteriaNetⓘ	no	84.70	no
125439	spore_formation	BacteriaNetⓘ	no	79.71	no

Predictions from bacterial phenotypic traits through improved machine learning using high-quality, curated datasets based on: Mycolicibacterium aurum NCTC10437
NCBI: GCA_900637195.1

@ref	Trait	Model	Prediction	Confidence in %	In training data
125438	gram-positive	gram-positiveⓘ	yes	91.37	no
125438	anaerobic	anaerobicⓘ	no	98.24	yes
125438	aerobic	aerobicⓘ	yes	90.39	no
125438	spore-forming	spore-formingⓘ	no	55.24	no
125438	thermophilic	thermophileⓘ	no	96.50	yes
125438	flagellated	motile2+ⓘ	no	86.87	no

Literature

Topic	Title	Authors	Journal	DOI	Year
	Crystal structure and anti-mycobacterial evaluation of 2-(cyclo-hexyl-meth-yl)-7-nitro-5-(tri-fluoro-meth-yl)benzo[d]iso-thia-zol-3(2H)-one.	Richter A, Goddard R, Imming P, Seidel RW.	Acta Crystallogr E Crystallogr Commun	10.1107/s2056989023010137	2023
	BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis.	Richter A, Seidel RW, Goddard R, Eckhardt T, Lehmann C, Dorner J, Siersleben F, Sondermann T, Mann L, Patzer M, Jager C, Reiling N, Imming P.	ACS Med Chem Lett	10.1021/acsmedchemlett.2c00215	2022
Pathogenicity	Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents.	Maafi N, Mamun AA, Jandourek O, Marikova J, Breiterova K, Diepoltova A, Konecna K, Hostalkova A, Hulcova D, Kunes J, Kohelova E, Koutova D, Safratova M, Novakova L, Cahlikova L.	Molecules	10.3390/molecules26196023	2021
	5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation.	Ambrozkiewicz W, Kucerova-Chlupacova M, Jandourek O, Konecna K, Paterova P, Barta P, Vinsova J, Dolezal M, Zitko J.	Molecules	10.3390/molecules25071561	2020
	Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity.	Bouz G, Semelkova L, Jandourek O, Konecna K, Paterova P, Navratilova L, Kubicek V, Kunes J, Dolezal M, Zitko J.	Molecules	10.3390/molecules24071212	2019
Pathogenicity	Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.	Bouz G, Juhas M, Niklova P, Jandourek O, Paterova P, Janousek J, Tumova L, Kovalikova Z, Kastner P, Dolezal M, Zitko J.	Molecules	10.3390/molecules22101797	2017
Pathogenicity	N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.	Juhas M, Kucerova L, Horacek O, Jandourek O, Kubicek V, Konecna K, Kucera R, Barta P, Janousek J, Paterova P, Kunes J, Dolezal M, Zitko J.	Molecules	10.3390/molecules25071518	2020
	A novel real-time PCR assay for specific detection and quantification of Mycobacterium avium subsp. paratuberculosis in milk with the inherent possibility of differentiation between viable and dead cells.	Dzieciol M, Volgger P, Khol J, Baumgartner W, Wagner M, Hein I.	BMC Res Notes	10.1186/1756-0500-3-251	2010
Phylogeny	Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera.	Gupta RS, Lo B, Son J.	Front Microbiol	10.3389/fmicb.2018.00067	2018
	Investigation of the antimycobacterial activity of African medicinal plants combined with chemometric analysis to identify potential leads.	Moyo P, Ofori M, Bodede OS, Wooding M, Khorommbi NK, McGaw LJ, Danquah CA, Maharaj VJ.	Sci Rep	10.1038/s41598-024-65369-7	2024
Pathogenicity	Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.	Solnier J, Martin L, Bhakta S, Bucar F.	Molecules	10.3390/molecules25030734	2020
	In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China.	Zhu R, Shang Y, Chen S, Xiao H, Ren R, Wang F, Xue Y, Li L, Li Y, Chu N, Huang H.	Microbiol Spectr	10.1128/spectrum.01372-22	2022
	Synthesis and Biological Evaluation of a Novel C8-Pyrrolobenzodiazepine (PBD) Adenosine Conjugate. A Study on the Role of the PBD Ring in the Biological Activity of PBD-Conjugates.	Ferguson L, Bhakta S, Fox KR, Wells G, Brucoli F.	Molecules	10.3390/molecules25051243	2020
	Himalaquinones A-G, Angucyclinone-Derived Metabolites Produced by the Himalayan Isolate Streptomyces sp. PU-MM59.	Zhang Y, Cheema MT, Ponomareva LV, Ye Q, Liu T, Sajid I, Rohr J, She QB, Voss SR, Thorson JS, Shaaban KA.	J Nat Prod	10.1021/acs.jnatprod.1c00192	2021
	In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.	Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H.	Microbiol Spectr	10.1128/spectrum.03238-22	2023
	C-1 Substituted isoquinolines potentiate the antimycobacterial activity of rifampicin and ethambutol.	Martin LT, Lamming ED, Maitra A, Mortazavi PN, Roddan R, Ward JM, Bhakta S, Hailes HC.	Front Antibiot	10.3389/frabi.2023.1095013	2023
	In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus.	Zhu R, Yu X, Zhang T, Kong Y, Wang F, Jia J, Xue Y, Huang H.	Front Microbiol	10.3389/fmicb.2022.926361	2022
Metabolism	Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated Streptomyces.	Wang X, Elshahawi SI, Ponomareva LV, Ye Q, Liu Y, Copley GC, Hower JC, Hatcher BE, Kharel MK, Van Lanen SG, She QB, Voss SR, Thorson JS, Shaaban KA.	J Nat Prod	10.1021/acs.jnatprod.9b01015	2019
Metabolism	Baraphenazines A-G, Divergent Fused Phenazine-Based Metabolites from a Himalayan Streptomyces.	Wang X, Abbas M, Zhang Y, Elshahawi SI, Ponomareva LV, Cui Z, Van Lanen SG, Sajid I, Voss SR, Shaaban KA, Thorson JS.	J Nat Prod	10.1021/acs.jnatprod.9b00289	2019
Metabolism	Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.	Rindi L.	Int J Mol Sci	10.3390/ijms21124191	2020
Metabolism	Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.	Abbas M, Elshahawi SI, Wang X, Ponomareva LV, Sajid I, Shaaban KA, Thorson JS.	J Nat Prod	10.1021/acs.jnatprod.8b00720	2018
Pathogenicity	In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China.	Yu X, Gao X, Li C, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H.	Antimicrob Agents Chemother	10.1128/aac.00031-19	2019
Metabolism	Characterization of cultures enriched from acidic polycyclic aromatic hydrocarbon-contaminated soil for growth on pyrene at low pH.	Uyttebroek M, Vermeir S, Wattiau P, Ryngaert A, Springael D.	Appl Environ Microbiol	10.1128/aem.02837-06	2007
	Antibacterial and Cytotoxic Actinomycins Y₆-Y₉ and Zp from Streptomyces sp. Strain Gö-GS12.	Cai W, Wang X, Elshahawi SI, Ponomareva LV, Liu X, McErlean MR, Cui Z, Arlinghaus AL, Thorson JS, Van Lanen SG.	J Nat Prod	10.1021/acs.jnatprod.6b00742	2016
Metabolism	Mycolic acid synthesis: a target for ethionamide in mycobacteria?	Quemard A, Laneelle G, Lacave C.	Antimicrob Agents Chemother	10.1128/aac.36.6.1316	1992
Metabolism	Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.	Quemard A, Lacave C, Laneelle G.	Antimicrob Agents Chemother	10.1128/aac.35.6.1035	1991
Enzymology	Molecular detection of Mycobacterium bovis and Mycobacterium bovis BCG (Pasteur) in soil.	Young JS, Gormley E, Wellington EM.	Appl Environ Microbiol	10.1128/aem.71.4.1946-1952.2005	2005
	Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.	Dhandayuthapani S, Zhang Y, Mudd MH, Deretic V.	J Bacteriol	10.1128/jb.178.12.3641-3649.1996	1996
Pathogenicity	Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.	Renau TE, Gage JW, Dever JA, Roland GE, Joannides ET, Shapiro MA, Sanchez JP, Gracheck SJ, Domagala JM, Jacobs MR, Reynolds RC.	Antimicrob Agents Chemother	10.1128/aac.40.10.2363	1996
Phylogeny	Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum.	Zhu L, Jiang G, Wang S, Wang C, Li Q, Yu H, Zhou Y, Zhao B, Huang H, Xing W, Mitchelson K, Cheng J, Zhao Y, Guo Y.	J Clin Microbiol	10.1128/jcm.00158-10	2010
Pathogenicity	Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.	Guzman JD, Pesnot T, Barrera DA, Davies HM, McMahon E, Evangelopoulos D, Mortazavi PN, Munshi T, Maitra A, Lamming ED, Angell R, Gershater MC, Redmond JM, Needham D, Ward JM, Cuca LE, Hailes HC, Bhakta S.	J Antimicrob Chemother	10.1093/jac/dkv010	2015
	Prospecting environmental mycobacteria: combined molecular approaches reveal unprecedented diversity.	Pontiroli A, Khera TT, Oakley BB, Mason S, Dowd SE, Travis ER, Erenso G, Aseffa A, Courtenay O, Wellington EM.	PLoS One	10.1371/journal.pone.0068648	2013
Enzymology	Bacteremia caused by Mycobacterium neoaurum.	Davison MB, McCormack JG, Blacklock ZM, Dawson DJ, Tilse MH, Crimmins FB.	J Clin Microbiol	10.1128/jcm.26.4.762-764.1988	1988
	Specificities and functions of the recA and pps1 intein genes of Mycobacterium tuberculosis and application for diagnosis of tuberculosis.	Saves I, Lewis LA, Westrelin F, Warren R, Daffe M, Masson JM.	J Clin Microbiol	10.1128/jcm.40.3.943-950.2002	2002
	Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids.	Saito H, Tomioka H, Yoneyama T.	Antimicrob Agents Chemother	10.1128/aac.26.2.164	1984
	Compilation of small ribosomal subunit RNA structures.	Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R.	Nucleic Acids Res	10.1093/nar/21.13.3025	1993
Phylogeny	The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria.	Stahl DA, Urbance JW.	J Bacteriol	10.1128/jb.172.1.116-124.1990	1990
	Flavonoids of Chromolaena odorata (L.) R.M.King & H.Rob. as potential leads for treatment against tuberculosis.	Omokhua-Uyi AG, Madikizela B, Aro AO, Abdalla MA, Van Staden J, McGaw LJ.	S Afr J Bot	10.1016/j.sajb.2023.05.002	2023
Transcriptome	Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages.	Lu L, Wei R, Bhakta S, Waddell SJ, Boix E.	Antibiotics (Basel)	10.3390/antibiotics10020097	2021
Pathogenicity	Acetone leaf extracts of some South African trees with high activity against Escherichia coli also have good antimycobacterial activity and selectivity index.	Elisha IL, Botha FS, Madikizela B, McGaw LJ, Eloff JN.	BMC Complement Altern Med	10.1186/s12906-017-1831-z	2017
	3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine N-acetyltransferase, in Mycobacteria.	Agre N, Tawari N, Maitra A, Gupta A, Munshi T, Degani M, Bhakta S.	Antibiotics (Basel)	10.3390/antibiotics9070368	2020
	Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs.	Asai M, Li Y, Newton SM, Robertson BD, Langford PR.	FEMS Microbiol Rev	10.1093/femsre/fuad011	2023
Pathogenicity	Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages.	Lu L, Arranz-Trullen J, Prats-Ejarque G, Pulido D, Bhakta S, Boix E.	Front Immunol	10.3389/fimmu.2019.01500	2019
Pathogenicity	Extracts of six Rubiaceae species combined with rifampicin have good in vitro synergistic antimycobacterial activity and good anti-inflammatory and antioxidant activities.	Aro AO, Dzoyem JP, Eloff JN, McGaw LJ.	BMC Complement Altern Med	10.1186/s12906-016-1355-y	2016
Transcriptome	Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model.	Lu L, Wei R, Prats-Ejarque G, Goetz M, Wang G, Torrent M, Boix E.	Cell Mol Life Sci	10.1007/s00018-020-03695-5	2021
	A comprehensive study of the potential phytomedicinal use and toxicity of invasive Tithonia species in South Africa.	Omokhua AG, Abdalla MA, Van Staden J, McGaw LJ.	BMC Complement Altern Med	10.1186/s12906-018-2336-0	2018
Pathogenicity	Fractions and isolated compounds from Oxyanthus speciosus subsp. stenocarpus (Rubiaceae) have promising antimycobacterial and intracellular activity.	Aro AO, Dzoyem JP, Awouafack MD, Selepe MA, Eloff JN, McGaw LJ.	BMC Complement Altern Med	10.1186/s12906-019-2520-x	2019
Pathogenicity	Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection.	Rodriguez-Carlos A, Raul A, Jacobo-Delgado YM, Serrano CJ, Santos-Mena A, De Jesus-Gonzalez LA, Boix E, Rivas-Santiago B.	Can J Microbiol	10.1139/cjm-2023-0127	2024
	Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killed Mycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle.	Abdallah F, Bazzi S, Akle C, Bahr GM, Echtay KS.	Front Endocrinol (Lausanne)	10.3389/fendo.2024.1427058	2024
	Safety evaluation and bioassay-guided isolation of antimycobacterial compounds from Morella salicifolia root ethanolic extract.	Marealle AI, Innocent E, Andrae-Marobela K, Qwarse M, Machumi F, Nondo RSO, Heydenreich M, Moshi MJ.	J Ethnopharmacol	10.1016/j.jep.2022.115501	2022
	The Epiphyte Bacillus sp. G2112 Produces a Large Diversity of Nobilamide Peptides That Promote Biofilm Formation in Pseudomonads and Mycobacterium aurum.	Iloabuchi K, Spiteller D.	Biomolecules	10.3390/biom14101244	2024
	Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB/RIF Ultra: Fact or fiction?	Opperman CJ, Ntshangase Z, Gumede M, Singh S, Ghebrekristos Y, Warren R, Goosen W.	S Afr J Infect Dis	10.4102/sajid.v39i1.576	2024
Metabolism	Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.	Shyam M, Bhattacharje G, Daniel C, Kumar A, Yadav P, Mukherjee P, Singh S, Das AK, Narender T, Singh A, Jayaprakash V, Bhakta S.	Molecules	10.3390/molecules28248115	2023
	Bioactive constituents from Malvastrum coromandelianum (L.) Garcke leaf extracts	Aderogba MA, Madikizela B, McGaw LJ.	S Afr J Bot		2019
	Fitness Cost and Compensatory Evolution in Levofloxacin-Resistant Mycobacterium aurum.	Pi R, Liu Q, Takiff HE, Gao Q.	Antimicrob Agents Chemother	10.1128/aac.00224-20	2020
Pathogenicity	Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.	Kratky M, Jandourek O, Baranyai Z, Novotna E, Stolarikova J, Bosze S, Vinsova J.	Eur J Med Chem	10.1016/j.ejmech.2019.111578	2019
Pathogenicity	Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives.	Agre N, Degani M, Gupta A, Bhakta S, Ray MK.	Arch Pharm (Weinheim)	10.1002/ardp.201900068	2019
	Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.	Nyambo K, Tapfuma KI, Adu-Amankwaah F, Julius L, Baatjies L, Niang IS, Smith L, Govender KK, Ngxande M, Watson DJ, Wiesner L, Mavumengwana V.	Sci Rep	10.1038/s41598-024-57124-9	2024
	Noxious to ecosystems, but relevant to pharmacology: Four South African alien invasive plants with pharmacological potential	Omokhua AG, Madikizela B, Aro A, Uyi OO, Van Staden J, McGaw LJ.	S Afr J Bot		2018
	Characterization, antioxidant, antimycobacterial, antimicrobial effcts of Moroccan rosemary essential oil, and its synergistic antimicrobial potential with carvacrol.	Chraibi M, Farah A, Elamin O, Iraqui HM, Fikri-Benbrahim K.	J Adv Pharm Technol Res	10.4103/japtr.japtr_74_19	2020
Pathogenicity	Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem.	Huang W, Briffotaux J, Wang X, Liu L, Hao P, Cimino M, Buchieri MV, Namouchi A, Ainsa JA, Gicquel B.	Tuberculosis (Edinb)	10.1016/j.tube.2017.09.001	2017
Pathogenicity	Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis.	Buchieri MV, Cimino M, Rebollo-Ramirez S, Beauvineau C, Cascioferro A, Favre-Rochex S, Helynck O, Naud-Martin D, Larrouy-Maumus G, Munier-Lehmann H, Gicquel B.	J Med Chem	10.1021/acs.jmedchem.7b00726	2017
	Variable intraspecific response to climate change in a medicinally important African tree species, Vachellia sieberiana (DC.) (paperbark thorn).	Jinga P, Manyangadze T.	Ecol Evol	10.1002/ece3.11314	2024
	C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists.	Ferguson L, Madieh NS, Vaideanu A, Schatzlein A, Festa J, Singh H, Wells G, Bhakta S, Brucoli F.	Chem Biol Drug Des	10.1111/cbdd.14128	2023
Enzymology	Source-to-tap investigation of the occurrence of nontuberculous mycobacteria in a full-scale chloraminated drinking water system.	Dowdell KS, Potgieter SC, Olsen K, Lee S, Vedrin M, Caverly LJ, LiPuma JJ, Raskin L.	Appl Environ Microbiol	10.1128/aem.00609-24	2024
Pathogenicity	The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae.	Phelan J, Maitra A, McNerney R, Nair M, Gupta A, Coll F, Pain A, Bhakta S, Clark TG.	Int J Mycobacteriol	10.1016/j.ijmyco.2015.05.001	2015
	Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020.	EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Hilbert F, Lindqvist R, Nauta M, Peixe L, Ru G, Simmons M, Skandamis P, Suffredini E, Cocconcelli PS, Fernandez Escamez PS, Maradona MP, Querol A, Sijtsma L, Suarez JE, Sundh I, Vlak J, Barizzone F, Hempen M, Herman L.	EFSA J	10.2903/j.efsa.2021.6377	2021
Enzymology	Verification of Frequency in Species of Nontuberculous Mycobacteria in Kermanshah Drinking Water Supplies Using the PCR-Sequencing Method.	Mohajeri P, Yazdani L, Shahraki AH, Alvandi A, Atashi S, Farahani A, Almasi A, Rezaei M.	Microb Drug Resist	10.1089/mdr.2016.0064	2017
Pathogenicity	Antimycobacterial Activity and Low Cytotoxicity of Leaf Extracts of Some African Anacardiaceae Tree Species.	Kabongo-Kayoka PN, Eloff JN, Obi CL, McGaw LJ.	Phytother Res	10.1002/ptr.5706	2016
	Antimycobacterial activity against different pathogens and selectivity index of fourteen medicinal plants used in southern Africa to treat tuberculosis and respiratory ailments	Dzoyem JP, Aro AO, McGaw LJ, Eloff JN.	S Afr J Bot	10.1016/j.sajb.2015.08.002	2016
	Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases.	Ngabonziza JCS, Decroo T, Maniliho R, Habimana YM, Van Deun A, de Jong BC.	Open Forum Infect Dis	10.1093/ofid/ofab034	2021
	Structure-Based Design of an RNase Chimera for Antimicrobial Therapy.	Prats-Ejarque G, Lorente H, Villalba C, Anguita R, Lu L, Vazquez-Monteagudo S, Fernandez-Millan P, Boix E.	Int J Mol Sci	10.3390/ijms23010095	2021
	The 15-lipoxygenase inhibitory, antioxidant, antimycobacterial activity and cytotoxicity of fourteen ethnomedicinally used African spices and culinary herbs.	Dzoyem JP, Kuete V, McGaw LJ, Eloff JN.	J Ethnopharmacol	10.1016/j.jep.2014.08.007	2014
Pathogenicity	Some South African Rubiaceae Tree Leaf Extracts Have Antimycobacterial Activity Against Pathogenic and Non-pathogenic Mycobacterium Species.	Aro AO, Dzoyem JP, Hlokwe TM, Madoroba E, Eloff JN, McGaw LJ.	Phytother Res	10.1002/ptr.5338	2015
	Autoimmune keratitis in mycobacterium tuberculosis.	Rafiezadeh P, Schmack I, Shajari M, Kohnen T.	J Curr Ophthalmol	10.1016/j.joco.2018.03.001	2018
Genetics	Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.	Osei-Wusu S, Otchere ID, Morgan P, Musah AB, Siam IM, Asandem D, Afum T, Asare P, Asante-Poku A, Kusi KA, Gagneux S, Yeboah-Manu D.	PLoS One	10.1371/journal.pone.0255433	2021
	Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays.	Shyam M, Thakur A, Velez C, Daniel C, Acevedo O, Bhakta S, Jayaprakash V.	Front Antibiot	10.3389/frabi.2024.1362516	2024
	Isolation and characterization of antimicrobial compounds from Terminalia phanerophlebia Engl. & Diels leaf extracts.	Madikizela B, Aderogba MA, Finnie JF, Van Staden J.	J Ethnopharmacol	10.1016/j.jep.2014.09.003	2014
	Mycobacterium aurum is Unable to Survive Mycobacterium tuberculosis Latency Associated Stress Conditions: Implications as Non-suitable Model Organism.	Sood S, Yadav A, Shrivastava R.	Indian J Microbiol	10.1007/s12088-016-0564-x	2016
	Ultrasound-assisted extraction of Peucedanum ostruthium leaves: a feasible alternative to rhizomes for industrial applications	Chen C, Wang G, Kuo J, Lin Y, Huang H, Chang Y, Chung Y.	Front Pharmacol		2025
	The survival of mycobacteria in pure human urine.	Orumwense PO, Torvinen E, Heinonen-Tanski H.	Water Sci Technol	10.2166/wst.2013.052	2013
	Endofungal bacteria boost anthelminthic host protection with the biosurfactant symbiosin.	Buttner H, Pidot SJ, Scherlach K, Hertweck C.	Chem Sci	10.1039/d2sc04167g	2022
Pathogenicity	Antimycobacterial activities of selected medicinal plants from Zimbabwe against Mycobacterium aurum and Corynebacterium glutamicum.	Chimponda T, Mukanganyama S.	Trop Biomed		2010
Enzymology	[Methodology research and preliminary assessment of Mycobacterium tuberculosis detection by immunomagnetic beads combined with functionalized fluorescent quantum dots].	Ma H, Hu ZY, Wang YL, Qing LH, Chen HZ, Lu JM, Yang H.	Zhonghua Jie He He Hu Xi Za Zhi		2013
Pathogenicity	Activity of Scottish plant, lichen and fungal endophyte extracts against Mycobacterium aurum and Mycobacterium tuberculosis.	Gordien AY, Gray AI, Ingleby K, Franzblau SG, Seidel V.	Phytother Res	10.1002/ptr.2988	2010
Pathogenicity	An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis.	Gupta A, Bhakta S.	J Antimicrob Chemother	10.1093/jac/dks056	2012
	Enhanced rhamnolipid production by Pseudomonas aeruginosa under phosphate limitation	Clarke KG, Ballot F, Reid SJ.	World J Microbiol Biotechnol	10.1007/s11274-010-0402-y	2010
Phylogeny	Phylogenetic analysis of Mycobacterium aurum and Mycobacterium neoaurum with redescription of M. aurum culture collection strains.	Simmon KE, Low YY, Brown-Elliott BA, Wallace RJ, Petti CA.	Int J Syst Evol Microbiol	10.1099/ijs.0.007799-0	2009
	Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).	Gordien AY, Gray AI, Franzblau SG, Seidel V.	J Ethnopharmacol	10.1016/j.jep.2009.09.007	2009
Metabolism	Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening.	Gupta A, Bhakta S, Kundu S, Gupta M, Srivastava BS, Srivastava R.	J Antimicrob Chemother	10.1093/jac/dkp279	2009
	Taxonomic and Metabolomics Profiling of Actinobacteria Strains from Himalayan Collection Sites in Pakistan.	Cheema MT, Ponomareva LV, Liu T, Voss SR, Thorson JS, Shaaban KA, Sajid I.	Curr Microbiol	10.1007/s00284-021-02557-y	2021
	Deciphering kas operon locus in Mycobacterium aurum and genesis of a recombinant strain for rational-based drug screening.	Gupta N, Singh BN.	J Appl Microbiol	10.1111/j.1365-2672.2008.03888.x	2008
Metabolism	Aerobic biotransformation of alkyl branched aromatic alkanoic naphthenic acids via two different pathways by a new isolate of Mycobacterium.	Johnson RJ, West CE, Swaih AM, Folwell BD, Smith BE, Rowland SJ, Whitby C.	Environ Microbiol	10.1111/j.1462-2920.2011.02649.x	2012
Metabolism	Amide isosteres in structure-activity studies of antibacterial minor groove binders.	Khalaf AI, Anthony N, Breen D, Donoghue G, Mackay SP, Scott FJ, Suckling CJ.	Eur J Med Chem	10.1016/j.ejmech.2011.08.035	2011
	Distribution of non-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR-RFLP.	Nour-Neamatollahie A, Ebrahimzadeh N, Siadat SD, Vaziri F, Eslami M, Akhavan Sepahi A, Khanipour S, Masoumi M, Sakhaee F, Ghazanfari Jajin M, Bahrmand A, Fateh A.	Saudi J Biol Sci	10.1016/j.sjbs.2016.02.001	2017
Pathogenicity	Acidified nitrite enhances hydrogen peroxide disinfection of Acanthamoeba, bacteria and fungi.	Heaselgrave W, Andrew PW, Kilvington S.	J Antimicrob Chemother	10.1093/jac/dkq075	2010
	Compartmentalization of galactan biosynthesis in mycobacteria.	Savkova K, Danchenko M, Fabianova V, Bellova J, Bencurova M, Huszar S, Kordulakova J, Sivakova B, Barath P, Mikusova K.	J Biol Chem	10.1016/j.jbc.2024.105768	2024
	Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit Mycobacterium tuberculosis.	Pollo LAE, Martin EF, Machado VR, Cantillon D, Wildner LM, Bazzo ML, Waddell SJ, Biavatti MW, Sandjo LP.	Front Microbiol	10.3389/fmicb.2020.622629	2020
Pathogenicity	Antimycobacterial polyacetylenes from Levisticum officinale.	Schinkovitz A, Stavri M, Gibbons S, Bucar F.	Phytother Res	10.1002/ptr.2408	2008
	Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift.	Kalera K, Liu R, Lim J, Pathirage R, Swanson DH, Johnson UG, Stothard AI, Lee JJ, Poston AW, Woodruff PJ, Ronning DR, Eoh H, Swarts BM.	ACS Infect Dis	10.1021/acsinfecdis.4c00138	2024
	Factors enhancing lycopene production by a new Mycobacterium aurum mutant	Kerr S, Cale C, Cabral JMS, van Keulen F.	Biotechnol Lett		2004
	Free chlorine demand and cell survival of microbial suspensions.	Helbling DE, Vanbriesen JM.	Water Res	10.1016/j.watres.2007.06.006	2007
Pathogenicity	Mycobacterium aurum bacteremia in an immunocompromised child.	Koranyi KI, Ranalli MA.	Pediatr Infect Dis J	10.1097/01.inf.0000101787.08603.bb	2003
	Factors enhancing lycopene production by a new Mycobacterium aurum mutant.	Kerr S, Cale C, Cabral JM, van Keulen F.	Biotechnol Lett	10.1023/b:bile.0000012886.32311.4e	2004
Enzymology	Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450.	Bukhdruker S, Varaksa T, Grabovec I, Marin E, Shabunya P, Kadukova M, Grudinin S, Kavaleuski A, Gusach A, Gilep A, Borshchevskiy V, Strushkevich N.	Int J Mol Sci	10.3390/ijms21207683	2020
	In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms.	Madikizela B, Ndhlala AR, Finnie JF, Staden JV.	Evid Based Complement Alternat Med	10.1155/2013/840719	2013
Metabolism	Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies.	Tahir T, Shahzad MI, Tabassum R, Rafiq M, Ashfaq M, Hassan M, Kotwica-Mojzych K, Mojzych M.	J Enzyme Inhib Med Chem	10.1080/14756366.2021.1929949	2021
Pathogenicity	Sesquiterpenes from Warburgia ugandensis and their antimycobacterial activity.	Wube AA, Bucar F, Gibbons S, Asres K.	Phytochemistry	10.1016/j.phytochem.2005.07.018	2005
Pathogenicity	Synthesis and antileprosy activity of some dialkyldithiocarbamates.	Makarov V, Riabova OB, Yuschenko A, Urlyapova N, Daudova A, Zipfel PF, Mollmann U.	J Antimicrob Chemother	10.1093/jac/dkl095	2006
	Bioactive diterpenes and sesquiterpenes from the rhizomes of wild ginger (Siphonochilus aethiopicus (Schweinf) B.L Burtt).	Igoli NP, Obanu ZA, Gray AI, Clements C.	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v9i1.13	2012
Enzymology	Fly-attracting volatiles produced by Rhodococcus fascians and Mycobacterium aurum isolated from myiatic lesions of sheep.	Khoga JM, Toth E, Marialigeti K, Borossay J.	J Microbiol Methods	10.1016/s0167-7012(01)00330-x	2002
Pathogenicity	Sophora flavescens protects against mycobacterial Trehalose Dimycolate-induced lung granuloma by inhibiting inflammation and infiltration of macrophages.	Liu D, Chan BC, Cheng L, Tsang MS, Zhu J, Wong CW, Jiao D, Chan HY, Leung PC, Lam CW, Wong CK.	Sci Rep	10.1038/s41598-018-22286-w	2018
	First isolation of Mycobacterium spp. in Mullus spp. in Turkey.	Sevim P, Ozer S, Rad F.	Iran J Vet Res		2015
	Phenotypic and Genotypic Investigation of Two Representative Strains of Microbacterium Species Isolated From Micro-Filtered Milk: Growth Capacity and Spoilage-Potential Assessment.	Bellassi P, Cappa F, Fontana A, Morelli L.	Front Microbiol	10.3389/fmicb.2020.554178	2020
	Structural and functional analysis of the gene cluster encoding carotenoid biosynthesis in Mycobacterium aurum A+.	Viveiros M, Krubasik P, Sandmann G, Houssaini-Iraqui M.	FEMS Microbiol Lett	10.1111/j.1574-6968.2000.tb09143.x	2000
Metabolism	Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis.	Piddock LJ, Ricci V.	J Antimicrob Chemother	10.1093/jac/45.5.681	2000
Pathogenicity	Synthesis and bioevaluation of glycosyl ureas as alpha-glucosidase inhibitors and their effect on mycobacterium.	Tewari N, Tiwari VK, Mishra RC, Tripathi RP, Srivastava AK, Ahmad R, Srivastava R, Srivastava BS.	Bioorg Med Chem	10.1016/s0968-0896(03)00214-1	2003
Pathogenicity	In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.	Seidel V, Taylor PW.	Int J Antimicrob Agents	10.1016/j.ijantimicag.2003.11.008	2004
	Chalcones, stilbenes and ketones have anti-infective properties via inhibition of bacterial drug-efflux and consequential synergism with antimicrobial agents.	Hellewell L, Bhakta S.	Access Microbiol	10.1099/acmi.0.000105	2020
Pathogenicity	Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.	Deb DK, Srivastava KK, Srivastava R, Srivastava BS.	Biochem Biophys Res Commun	10.1006/bbrc.2000.3957	2000
Metabolism	Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane.	Chiaradia L, Lefebvre C, Parra J, Marcoux J, Burlet-Schiltz O, Etienne G, Tropis M, Daffe M.	Sci Rep	10.1038/s41598-017-12718-4	2017
	Heat-killed Mycolicibacterium aurum Aogashima: An environmental nonpathogenic actinobacteria under development as a safe novel food ingredient.	Nouioui I, Dye T.	Food Sci Nutr	10.1002/fsn3.2413	2021
Metabolism	Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.	Piddock LJ, Williams KJ, Ricci V.	J Antimicrob Chemother	10.1093/jac/45.2.159	2000
Pathogenicity	Recombinant Mycobacterium aurum expressing Escherichia coli beta-galactosidase in high throughput screening of antituberculosis drugs.	Srivastava R, Kumar D, Srivastava BS.	Biochem Biophys Res Commun	10.1006/bbrc.1997.7689	1997
Metabolism	Intracellular localization of the mycobacterial stressosome complex.	Ramesh M, Nitharwal RG, Behra PRK, Fredrik Pettersson BM, Dasgupta S, Kirsebom LA.	Sci Rep	10.1038/s41598-021-89069-8	2021
	Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of Pseudomonas aeruginosa Phages.	Danis-Wlodarczyk KM, Cai A, Chen A, Gittrich MR, Sullivan MB, Wozniak DJ, Abedon ST.	Pharmaceuticals (Basel)	10.3390/ph14111162	2021
Pathogenicity	Lactate Alters Metabolism in Human Macrophages and Improves Their Ability to Kill Mycobacterium tuberculosis.	O Maoldomhnaigh C, Cox DJ, Phelan JJ, Mitermite M, Murphy DM, Leisching G, Thong L, O'Leary SM, Gogan KM, McQuaid K, Coleman AM, Gordon SV, Basdeo SA, Keane J.	Front Immunol	10.3389/fimmu.2021.663695	2021
	Biology, chemistry, and pharmacological activity of Kigelia africana (Bignoniaceae) and Garcinia kola (Clusiaceae) - a review.	Assanti G, Kaur R, Nizard S, Pollack-Blackwood E, Rafferty B, Priano C, Fernandez Romero JA, Koroch AR.	J Med Act Plants	10.7275/hece-wp36	2022
	Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds.	Liu R, Markley L, Miller PA, Franzblau S, Shetye G, Ma R, Savkova K, Mikusova K, Lee BS, Pethe K, Moraski GC, Miller MJ.	RSC Med Chem	10.1039/d0md00390e	2021
	Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex.	Asai M, Li Y, Khara JS, Robertson BD, Langford PR, Newton SM.	Front Microbiol	10.3389/fmicb.2019.02630	2019
	Nutritional and pharmacological potentials of orphan legumes: Subfamily faboideae.	Ogbole OO, Akin-Ajani OD, Ajala TO, Ogunniyi QA, Fettke J, Odeku OA.	Heliyon	10.1016/j.heliyon.2023.e15493	2023
Metabolism	Antimycobacterial activity of lichen metabolites in vitro.	Ingolfsdottir K, Chung GA, Skulason VG, Gissurarson SR, Vilhelmsdottir M.	Eur J Pharm Sci	10.1016/s0928-0987(97)00078-x	1998
Enzymology	Partial characterization of a major autolysin from Mycobacterium phlei.	Li ZS, Beveridge TJ, Betts J, Clarke AJ.	Microbiology (Reading)	10.1099/13500872-145-1-169	1999
Enzymology	Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.	Shilpi JA, Ali MT, Saha S, Hasan S, Gray AI, Seidel V.	In Silico Pharmacol	10.1186/s40203-015-0014-1	2015
Metabolism	Lipid domains of mycobacteria studied with fluorescent molecular probes.	Christensen H, Garton NJ, Horobin RW, Minnikin DE, Barer MR.	Mol Microbiol	10.1046/j.1365-2958.1999.01304.x	1999
	Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae).	Mozirandi W, Tagwireyi D, Mukanganyama S.	BMC Complement Altern Med	10.1186/s12906-019-2657-7	2019
Enzymology	Identification of the newly described Mycobacterium poriferae from tuberculous lesions of snakehead fish (Channa striatus).	Tortoli E, Bartoloni A, Bozzetta E, Burrini C, Lacchini C, Mantella A, Penati V, Tullia Simonetti M, Ghittino C.	Comp Immunol Microbiol Infect Dis	10.1016/0147-9571(95)00021-6	1996
	Transformation of Mycobacterium aurum and Mycobacterium smegmatis with the broad host-range gram-negative cosmid vector pJRD215.	Hermans J, Martin C, Huijberts GN, Goosen T, de Bont JA.	Mol Microbiol	10.1111/j.1365-2958.1991.tb00803.x	1991
Enzymology	Cloning and expression of Mycobacterium aurum carotenogenesis genes in Mycobacterium smegmatis.	Houssaini-Iraqui M, Lazraq MH, Clavel-Seres S, Rastogi N, David HL.	FEMS Microbiol Lett	10.1016/0378-1097(92)90653-6	1992
Metabolism	Formation of progesterone and 1-dehydroprogesterone from cholesterol in fermentation cultures of Mycobacterium aurum.	Horhold C, Bohme KH.	J Steroid Biochem	10.1016/0022-4731(90)90128-f	1990
Metabolism	Ethylenic mycolic acid biosynthesis: extension of the biosynthetic model using cell-free extracts of Mycobacterium aurum and Mycobacterium smegmatis.	Lopez-Marin LM, Quemard A, Laneelle G, Lacave C.	Biochim Biophys Acta	10.1016/0005-2760(91)90150-g	1991
Metabolism	Cell-free synthesis of mycolic acids in Mycobacterium aurum: radioactivity distribution in newly synthesized acids and presence of cell wall in the system.	Lacave C, Quemard A, Laneelle G.	Biochim Biophys Acta	10.1016/0005-2760(90)90203-a	1990
Enzymology	Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.	Heym B, Cole ST.	Res Microbiol	10.1016/0923-2508(92)90067-x	1992
Metabolism	Mycolic acid metabolic filiation and location in Mycobacterium aurum and Mycobacterium phlei.	Lacave C, Laneelle MA, Daffe M, Montrozier H, Laneelle G.	Eur J Biochem	10.1111/j.1432-1033.1989.tb14747.x	1989
Enzymology	Mycolic acids of Mycobacterium aurum. Structure and biogenetic implications.	Laneelle MA, Lacave C, Daffe M, Laneelle G.	Eur J Biochem	10.1111/j.1432-1033.1988.tb14416.x	1988
Pathogenicity	Colistin (polymyxin E)--induced cell leakage in Mycobacterium aurum.	Rastogi N, Henrotte JG, David HL.	Zentralbl Bakteriol Mikrobiol Hyg A	10.1016/s0176-6724(87)80198-0	1987
Pathogenicity	Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum.	Bosne-David S, Bricard L, Ramiandrasoa F, DeRoussent A, Kunesch G, Andremont A.	Antimicrob Agents Chemother	10.1128/aac.41.8.1837	1997
Cultivation	The growth of mycobacteria in liquid medium is influenced by the dimension of glass wall in contact with the medium.	Tsukamura M.	Microbiol Immunol	10.1111/j.1348-0421.1990.tb01068.x	1990
	Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores.	Rangel M, Moniz T, Silva AMN, Leite A.	Pharmaceuticals (Basel)	10.3390/ph11040110	2018
	A Retrospective Study of 17 Cases of Mycobacteriosis in Domestic Ferrets (Mustela Putorius furo) between 2005 and 2013.	Mentre V, Bulliot C.	J Exot Pet Med	10.1053/j.jepm.2015.06.019	2015
	Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies.	Bouz G, Juhas M, Pausas Otero L, Paredes de la Red C, Jandourek O, Konecna K, Paterova P, Kubicek V, Janousek J, Dolezal M, Zitko J.	Molecules	10.3390/molecules25010138	2019
Phylogeny	Identification of Mycobacterium neoaurum isolated from a neutropenic patient with catheter-related bacteremia by 16S rRNA sequencing.	Woo PC, Tsoi HW, Leung KW, Lum PN, Leung AS, Ma CH, Kam KM, Yuen KY.	J Clin Microbiol	10.1128/jcm.38.9.3515-3517.2000	2000
	Ethnobotanical Study of Plants Used in the Management of HIV/AIDS-Related Diseases in Livingstone, Southern Province, Zambia.	Chinsembu KC.	Evid Based Complement Alternat Med	10.1155/2016/4238625	2016
	Branched fatty acids from Mycobacterium aurum.	Rafidinarivo E, Savagnac A, Lacave C, Prome JC.	Biochim Biophys Acta	10.1016/0005-2760(82)90035-2	1982
Metabolism	Conversion of sterols and triterpenes by mycobacteria. I Formation of progesterone and 1-dehydroprogesterone from Mycobacterium aurum, strain A+.	Prome D, Lacave C, Monsarrat B, David H, Prome JC.	Biochim Biophys Acta	10.1016/0005-2760(83)90098-x	1983
	Antimycobacterial susceptibility testing methods for natural products research.	Sanchez JG, Kouznetsov VV.	Braz J Microbiol	10.1590/s1517-83822010000200001	2010
	Ultrastructural and chemical studies on wall-deficient forms, spheroplasts and membrane vesicles from Mycobacterium aurum.	Rastogi N, David HL.	J Gen Microbiol	10.1099/00221287-124-1-71	1981
Pathogenicity	Studies on clofazimine-resistance in mycobacteria: is the inability to isolate drug-resistance mutants related to its mode of action?	David HL, Rastogi N, Clavel-Seres S, Clement F.	Zentralbl Bakteriol Mikrobiol Hyg A	10.1016/s0176-6724(87)80043-3	1987
Metabolism	Mutations affecting pigment synthesis in Mycobacterium aurum.	Levy-Frebault V, David HL.	J Gen Microbiol	10.1099/00221287-115-2-317	1979
	Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids.	Jurkowitz MS, Azad AK, Monsma PC, Keiser TL, Kanyo J, Lam TT, Bell CE, Schlesinger LS.	J Biol Chem	10.1016/j.jbc.2022.101849	2022
	[New heterocyclic derivatives of benzimidazole with germicidal activity. III. Synthesis and activity of derivatives of (formyl-5'-furyl-2')-2-benzimidazole with different substitutions at position 5].	Alunni Bistocchi G, De Meo G, Pedini M, Ricci A, Bastianini L, Sposini T, Sbaraglia G, Jacquignon P.	Farmaco Sci		1986
Metabolism	Conversion of sterols and triterpenes by mycobacteria. II. Transformation of 7-oxygenated sterols into androstane derivatives via a 7-deoxygenation.	Prome D, Clave C, Escoffier B, Prome JC.	Biochim Biophys Acta	10.1016/0005-2760(87)90084-1	1987
	Biochemical and cultural analysis of mycobacterial recombinants obtained by spheroplast fusion.	Rastogi N, Rauzier JY, Papa FP, David HL.	Ann Inst Pasteur Microbiol (1985)	10.1016/s0769-2609(86)80018-7	1986
Phylogeny	Mycobactins as chemotaxonomic characters for some rapidly growing mycobacteria.	Hall RM, Ratledge C.	J Gen Microbiol	10.1099/00221287-130-8-1883	1984
	Spheroplast fusion as a mode of genetic recombination in mycobacteria.	Rastogi N, David HL, Rafidinarivo E.	J Gen Microbiol	10.1099/00221287-129-4-1227	1983
Pathogenicity	High-throughput screen for detecting antimycobacterial agents.	Chung GA, Aktar Z, Jackson S, Duncan K.	Antimicrob Agents Chemother	10.1128/aac.39.10.2235	1995
	Fatty acid composition and mycolic acid pattern of some chromogenic mycobacteria.	Valero-Guillen PL, Pacheco F, Martin-Luengo F.	J Appl Bacteriol	10.1111/j.1365-2672.1985.tb03309.x	1985
	Mycolic acid patterns of some rapidly-growing species of Mycobacterium.	Minnikin DE, Minnikin SM, Parlett JH, Goodfellow M.	Zentralbl Bakteriol Mikrobiol Hyg A	10.1016/s0176-6724(85)80076-6	1985
	Efficacy of Artemisia afra phytotherapy in experimental tuberculosis.	Ntutela S, Smith P, Matika L, Mukinda J, Arendse H, Allie N, Estes DM, Mabusela W, Folb P, Steyn L, Johnson Q, Folk WR, Syce J, Jacobs M.	Tuberculosis (Edinb)	10.1016/s1472-9792(09)70009-5	2009
Pathogenicity	Native New Zealand plants with inhibitory activity towards Mycobacterium tuberculosis.	Earl EA, Altaf M, Murikoli RV, Swift S, O'Toole R.	BMC Complement Altern Med	10.1186/1472-6882-10-25	2010
Metabolism	Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.	Madacki J, Laval F, Grzegorzewicz A, Lemassu A, Zahorszka M, Arand M, McNeil M, Daffe M, Jackson M, Laneelle MA, Kordulakova J.	J Biol Chem	10.1074/jbc.ra117.000246	2018
Phylogeny	A High-Throughput Approach for Identification of Nontuberculous Mycobacteria in Drinking Water Reveals Relationship between Water Age and Mycobacterium avium.	Haig SJ, Kotlarz N, LiPuma JJ, Raskin L.	mBio	10.1128/mbio.02354-17	2018
Phylogeny	Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.	Apiwattankul N, Flynn PM, Hayden RT, Adderson EE.	J Pediatric Infect Dis Soc	10.1093/jpids/piu038	2015
Pathogenicity	Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.	Ribeiro AL, Degiacomi G, Ewann F, Buroni S, Incandela ML, Chiarelli LR, Mori G, Kim J, Contreras-Dominguez M, Park YS, Han SJ, Brodin P, Valentini G, Rizzi M, Riccardi G, Pasca MR.	PLoS One	10.1371/journal.pone.0026675	2011
Phylogeny	Numerical analysis of relationships among rapidly growing, scotochromogenic mycobacteria.	Tsukamura M, Mizuno S.	J Gen Microbiol	10.1099/00221287-98-2-511	1977
Enzymology	In vivo and in vitro inhibition of rat liver glutathione transferases activity by extracts from Combretum zeyheri (Combretaceae) and Parinari curatellifolia (Chrysobalanaceae).	Gweshelo D, Muswe R, Mukanganyama S.	BMC Complement Altern Med	10.1186/s12906-016-1235-5	2016
Metabolism	Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen.	Scheich C, Szabadka Z, Vertessy B, Putter V, Grolmusz V, Schade M.	PLoS One	10.1371/journal.pone.0028428	2011
	Review on plant antimicrobials: a mechanistic viewpoint.	Khameneh B, Iranshahy M, Soheili V, Fazly Bazzaz BS.	Antimicrob Resist Infect Control	10.1186/s13756-019-0559-6	2019
Metabolism	Aerobic vinyl chloride metabolism in Mycobacterium aurum L1.	Hartmans S, De Bont JA.	Appl Environ Microbiol	10.1128/aem.58.4.1220-1226.1992	1992
	Characterization of temperate phage Che12 and construction of a new tool for diagnosis of tuberculosis.	Kumar V, Loganathan P, Sivaramakrishnan G, Kriakov J, Dusthakeer A, Subramanyam B, Chan J, Jacobs WR, Paranji Rama N.	Tuberculosis (Edinb)	10.1016/j.tube.2008.02.007	2008
Pathogenicity	Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.	Bardou F, Quemard A, Dupont MA, Horn C, Marchal G, Daffe M.	Antimicrob Agents Chemother	10.1128/aac.40.11.2459	1996
	Hypoxic Non-replicating Persistent Mycobacterium tuberculosis Develops Thickened Outer Layer That Helps in Restricting Rifampicin Entry.	Jakkala K, Ajitkumar P.	Front Microbiol	10.3389/fmicb.2019.02339	2019
Metabolism	Isolation and identification of a morpholine-degrading bacterium.	Cech JS, Hartman P, Slosarek M, Chudoba J.	Appl Environ Microbiol	10.1128/aem.54.2.619-621.1988	1988
	Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?	Abedon ST.	Antibiotics (Basel)	10.3390/antibiotics8040182	2019
Pathogenicity	Effects of antituberculosis and antileprosy drugs on mycobacteriophage D29 growth.	David HL, Clavel S, Clement F, Moniz-Pereira J.	Antimicrob Agents Chemother	10.1128/aac.18.2.357	1980
Metabolism	Benzothiazinones mediate killing of Corynebacterineae by blocking decaprenyl phosphate recycling involved in cell wall biosynthesis.	Grover S, Alderwick LJ, Mishra AK, Krumbach K, Marienhagen J, Eggeling L, Bhatt A, Besra GS.	J Biol Chem	10.1074/jbc.m113.522623	2014
Metabolism	IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria.	Baumgart M, Luder K, Grover S, Gatgens C, Besra GS, Frunzke J.	BMC Biol	10.1186/1741-7007-11-122	2013
Metabolism	Two new Mycobacterium strains and their role in toluene degradation in a contaminated stream.	Tay ST, Hemond HF, Polz MF, Polz MF, Cavanaugh CM, Dejesus I, Krumholz LR.	Appl Environ Microbiol	10.1128/aem.64.5.1715-1720.1998	1998
Enzymology	Genetic manipulation of carotenoid biosynthesis in the green sulfur bacterium Chlorobium tepidum.	Frigaard NU, Maresca JA, Yunker CE, Jones AD, Bryant DA.	J Bacteriol	10.1128/jb.186.16.5210-5220.2004	2004
Pathogenicity	Antibacterial action of colistin (polymyxin E) against Mycobacterium aurum.	David HL, Rastogi N.	Antimicrob Agents Chemother	10.1128/aac.27.5.701	1985
Pathogenicity	Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.	Andreu N, Fletcher T, Krishnan N, Wiles S, Robertson BD.	J Antimicrob Chemother	10.1093/jac/dkr472	2012
	Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species.	Ortalo-Magne A, Lemassu A, Laneelle MA, Bardou F, Silve G, Gounon P, Marchal G, Daffe M.	J Bacteriol	10.1128/jb.178.2.456-461.1996	1996
Metabolism	Strong impact on the polycyclic aromatic hydrocarbon (PAH)-degrading community of a PAH-polluted soil but marginal effect on PAH degradation when priming with bioremediated soil dominated by mycobacteria.	Johnsen AR, Schmidt S, Hybholt TK, Henriksen S, Jacobsen CS, Andersen O.	Appl Environ Microbiol	10.1128/aem.02236-06	2007
Enzymology	Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.	Pfyffer GE, Funke-Kissling P, Rundler E, Weber R.	J Clin Microbiol	10.1128/jcm.37.1.137-140.1999	1999
Metabolism	Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.	Gotte G, Menegazzi M.	Front Immunol	10.3389/fimmu.2019.02626	2019
	In vivo killing and degradation of Mycobacterium aurum within mouse peritoneal macrophages.	Silva MT, Appelberg R, Silva MN, Macedo PM.	Infect Immun	10.1128/iai.55.9.2006-2016.1987	1987
Pathogenicity	Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm.	Masselot F, Boulos A, Maurin M, Rolain JM, Raoult D.	Antimicrob Agents Chemother	10.1128/aac.47.5.1658-1664.2003	2003
Phylogeny	Use of sloppy molecular beacon probes for identification of mycobacterial species.	El-Hajj HH, Marras SA, Tyagi S, Shashkina E, Kamboj M, Kiehn TE, Glickman MS, Kramer FR, Alland D.	J Clin Microbiol	10.1128/jcm.02043-08	2009
	Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.	Ibrahim DA, Boucau J, Lajiness DH, Veleti SK, Trabbic KR, Adams SS, Ronning DR, Sucheck SJ.	Bioconjug Chem	10.1021/bc3004342	2012
Pathogenicity	Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.	Zhang Y, Dhandayuthapani S, Deretic V.	Proc Natl Acad Sci U S A	10.1073/pnas.93.23.13212	1996
Metabolism	Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.	Bhakta S, Besra GS, Upton AM, Parish T, Sholto-Douglas-Vernon C, Gibson KJ, Knutton S, Gordon S, DaSilva RP, Anderton MC, Sim E.	J Exp Med	10.1084/jem.20031956	2004
	Psoralea corylifolia L: Ethnobotanical, biological, and chemical aspects: A review.	Alam F, Khan GN, Asad MHHB.	Phytother Res	10.1002/ptr.6006	2018
	Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.	Frehel C, de Chastellier C, Lang T, Rastogi N.	Infect Immun	10.1128/iai.52.1.252-262.1986	1986
	Genotypic variation and stability of four variable-number tandem repeats and their suitability for discriminating strains of Mycobacterium leprae.	Truman R, Fontes AB, De Miranda AB, Suffys P, Gillis T.	J Clin Microbiol	10.1128/jcm.42.6.2558-2565.2004	2004
Metabolism	A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis.	Yuan Y, Barry CE.	Proc Natl Acad Sci U S A	10.1073/pnas.93.23.12828	1996
	Transposon mutagenesis of Mycobacterium marinum identifies a locus linking pigmentation and intracellular survival.	Gao LY, Groger R, Cox JS, Beverley SM, Lawson EH, Brown EJ.	Infect Immun	10.1128/iai.71.2.922-929.2003	2003
Enzymology	Identification of a lycopene beta-cyclase required for bacteriorhodopsin biogenesis in the archaeon Halobacterium salinarum.	Peck RF, Johnson EA, Krebs MP.	J Bacteriol	10.1128/jb.184.11.2889-2897.2002	2002
Enzymology	Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems.	Falkinham JO, Norton CD, LeChevallier MW.	Appl Environ Microbiol	10.1128/aem.67.3.1225-1231.2001	2001
Metabolism	Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.	Li XZ, Zhang L, Nikaido H.	Antimicrob Agents Chemother	10.1128/aac.48.7.2415-2423.2004	2004
Phylogeny	Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR.	Stinear T, Davies JK, Jenkin GA, Hayman JA, Oppedisano F, Johnson PD.	Appl Environ Microbiol	10.1128/aem.66.8.3206-3213.2000	2000
	Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum.	Pagan-Ramos E, Song J, McFalone M, Mudd MH, Deretic V.	J Bacteriol	10.1128/jb.180.18.4856-4864.1998	1998
	Chemical and biological properties of mycobactins isolated from various mycobacteria.	Snow GA, White AJ.	Biochem J	10.1042/bj1151031	1969
Genetics	Genome-Based Taxonomic Classification of the Phylum Actinobacteria.	Nouioui I, Carro L, Garcia-Lopez M, Meier-Kolthoff JP, Woyke T, Kyrpides NC, Pukall R, Klenk HP, Goodfellow M, Goker M.	Front Microbiol	10.3389/fmicb.2018.02007	2018
	Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones.	Madikizela B, Eckhardt T, Goddard R, Richter A, Lins A, Lehmann C, Imming P, Seidel RW	Med Chem Res	10.1007/s00044-021-02735-4	2021
	Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria.	Tran HT, Solnier J, Pferschy-Wenzig EM, Kunert O, Martin L, Bhakta S, Huynh L, Le TM, Bauer R, Bucar F	Antibiotics (Basel)	10.3390/antibiotics9070390	2020
Pathogenicity	Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.	Namouchi A, Cimino M, Favre-Rochex S, Charles P, Gicquel B	BMC Genomics	10.1186/s12864-017-3924-y	2017
Pathogenicity	Antibacterial activities of plants from Central Africa used traditionally by the Bakola pygmies for treating respiratory and tuberculosis-related symptoms.	Fomogne-Fodjo MC, Van Vuuren S, Ndinteh DT, Krause RW, Olivier DK	J Ethnopharmacol	10.1016/j.jep.2014.04.032	2014
Metabolism	Mycolic acid synthesis by Mycobacterium aurum cell-free extracts.	Lacave C, Laneelle MA, Laneelle G	Biochim Biophys Acta	10.1016/0005-2760(90)90159-u	1990
Phylogeny	Formal description of Mycobacterium neglectum sp. nov. and Mycobacterium palauense sp. nov., rapidly growing actinobacteria.	Nouioui I, Carro L, Sangal V, Jando M, Igual JM, Goodfellow M, Klenk HP.	Antonie Van Leeuwenhoek	10.1007/s10482-018-1029-5	2018
Phylogeny	Mycobacterium grossiae sp. nov., a rapidly growing, scotochromogenic species isolated from human clinical respiratory and blood culture specimens.	Paniz-Mondolfi AE, Greninger AL, Ladutko L, Brown-Elliott BA, Vasireddy R, Jakubiec W, Vasireddy S, Wallace RJ, Simmon KE, Dunn BE, Jackoway G, Vora SB, Quinn KK, Qin X, Campbell S.	Int J Syst Evol Microbiol	10.1099/ijsem.0.002216	2017
	Comparative Genomic Study of Vinyl Chloride Cluster and Description of Novel Species, Mycolicibacterium vinylchloridicum sp. nov.	Cortes-Albayay C, Sangal V, Klenk HP, Nouioui I.	Front Microbiol	10.3389/fmicb.2021.767895	2021
Phylogeny	Streptomyces polyantibioticus sp. nov., isolated from the banks of a river.	le Roes-Hill M, Meyers PR.	Int J Syst Evol Microbiol	10.1099/ijs.0.006171-0	2009
	Nonomuraea candida sp. nov., a new species from South African soil.	Roes Ml, Meyers PR.	Antonie Van Leeuwenhoek	10.1007/s10482-007-9187-x	2008
Phylogeny	Actinomadura napierensis sp. nov., isolated from soil in South Africa.	Cook AE, Roes ML, Meyers PR.	Int J Syst Evol Microbiol	10.1099/ijs.0.63359-0	2005
Phylogeny	Mycobacterium pyrenivorans sp. nov., a novel polycyclic-aromatic-hydrocarbon-degrading species.	Derz K, Klinner U, Schuphan I, Stackebrandt E, Kroppenstedt RM.	Int J Syst Evol Microbiol	10.1099/ijs.0.03003-0	2004
Phylogeny	Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia.	Brown-Elliott BA, Wallace RJ, Petti CA, Mann LB, McGlasson M, Chihara S, Smith GL, Painter P, Hail D, Wilson R, Simmon KE.	J Clin Microbiol	10.1128/jcm.00853-10	2010
Phylogeny	A new rapidly growing mycobacterial species, Mycobacterium murale sp. nov., isolated from the indoor walls of a children's day care centre.	Vuorio R, Andersson MA, Rainey FA, Kroppenstedt RM, Kampfer P, Busse HJ, Viljanen M, Salkinoja-Salonen M.	Int J Syst Bacteriol	10.1099/00207713-49-1-25	1999
Phylogeny	Mycolicibacterium baixiangningiae sp. nov. and Mycolicibacterium mengxianglii sp. nov., two new rapidly growing mycobacterial species.	Cheng Y, Lei W, Wang X, Tian Z, Liu H, Yang J, Lu S, Lai XH, Pu J, Huang Y, Zhang S, Yang C, Lian X, Bai Y, Wan K, Wang S, Xu J	Int J Syst Evol Microbiol	10.1099/ijsem.0.005019	2021
Phylogeny	Classification of a polycyclic aromatic hydrocarbon-metabolizing bacterium, Mycobacterium sp. strain PYR-1, as Mycobacterium vanbaalenii sp. nov.	Khan AA, Kim SJ, Paine DD, Cerniglia CE	Int J Syst Evol Microbiol	10.1099/00207713-52-6-1997	2002

References

#11447	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 43999
#20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )
#20216	Curators of the JMRC: Jena Microbial Resource Collection (JMRC):
#20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )
#41184	; Curators of the CIP;
#63730	Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 70546
#66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .
#67770	Japan Collection of Microorganism (JCM) ; Curators of the JCM;
#68369	Automatically annotated from API 20NE .
#68382	Automatically annotated from API zym .
#116641	Collection of Institut Pasteur ; Curators of the CIP; CIP 104465
#125438	Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 )
#125439	Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 .
#126262	A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 )

Content

About us

Mycobacterium aurum (DSM 43999, ATCC 23366, JCM 6366)

Name and taxonomic classification

Morphology

Cell morphology

Multimedia

Culture and growth conditions

Culture medium

Culture temp

Physiology and metabolism

Oxygen tolerance

Halophily

Observation

Metabolite utilization

Metabolite production

Metabolite tests

Enzymes

API zym

API 20NE

API biotype100

Isolation, sampling and environmental information

Isolation source categories

Isolation

Interaction and safety

Risk assessment

Sequence information

Genome sequences

Genome browser: GCA_900637195

16S sequences

GC content

Genome-based predictions

Predictions

Literature

Literature

References

BacDive

Help

Social Media